scholarly journals Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin

2019 ◽  
Vol 73 (3) ◽  
pp. 228-232 ◽  
Author(s):  
Hiromasa Otake ◽  
Yoichiro Sugizaki ◽  
Takayoshi Toba ◽  
Yuichiro Nagano ◽  
Yoshiro Tsukiyama ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document